{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:26:32Z","timestamp":1718411192303},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,13]]},"DOI":"10.7759\/cureus.62339","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T03:26:57Z","timestamp":1718335617000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond Occam's Razor: Concurrent Non-functional Pituitary Macroadenoma and Metastatic Hepatocellular Carcinoma in a Patient With Functional Cure of Hepatitis B"],"prefix":"10.7759","author":[{"given":"Yu-Ming","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Shiang","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tse-Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Shih-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2020.09.007","article-title":"Approach to fatigue: best practice","volume":"105","author":"Dukes JC","year":"2021","unstructured":"Dukes JC, Chakan M, Mills A, Marcaurd M. Approach to fatigue: best practice. Med Clin North Am. 2021, 105:137-48. 10.1016\/j.mcna.2020.09.007","journal-title":"Med Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2014.01.010","article-title":"Fatigue","volume":"98","author":"Wright J","year":"2014","unstructured":"Wright J, O'Connor KM. Fatigue. Med Clin North Am. 2014, 98:597-608. 10.1016\/j.mcna.2014.01.010","journal-title":"Med Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.1.6309","article-title":"Pituitary tumor registry: a novel clinical resource","volume":"85","author":"Drange MR","year":"2000","unstructured":"Drange MR, Fram NR, Herman-Bonert V, Melmed S. Pituitary tumor registry: a novel clinical resource. J Clin Endocrinol Metab. 2000, 85:168-74. 10.1210\/jcem.85.1.6309","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1415-1","article-title":"Impact of etiology, age and gender on onset and severity of hyponatremia in patients with hypopituitarism: retrospective analysis in a specialised endocrine unit","volume":"58","author":"Miljic D","year":"2017","unstructured":"Miljic D, Doknic M, Stojanovic M, Nikolic-Djurovic M, Petakov M, Popovic V, Pekic S. Impact of etiology, age and gender on onset and severity of hyponatremia in patients with hypopituitarism: retrospective analysis in a specialised endocrine unit. Endocrine. 2017, 58:312-9. 10.1007\/s12020-017-1415-1","journal-title":"Endocrine"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0493","article-title":"Management of endocrine disease: hypothyroidism-associated hyponatremia: mechanisms, implications and treatment","volume":"176","author":"Liamis G","year":"2017","unstructured":"Liamis G, Filippatos TD, Liontos A, Elisaf MS. Management of endocrine disease: hypothyroidism-associated hyponatremia: mechanisms, implications and treatment. Eur J Endocrinol. 2017, 176:R15-20. 10.1530\/EJE-16-0493","journal-title":"Eur J Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2010.530680","article-title":"Endocrine disorders: causes of hyponatremia not to neglect","volume":"43","author":"Liamis G","year":"2011","unstructured":"Liamis G, Milionis HJ, Elisaf M. Endocrine disorders: causes of hyponatremia not to neglect. Ann Med. 2011, 43:179-87. 10.3109\/07853890.2010.530680","journal-title":"Ann Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin SK","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, et al.. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016, 10:1-98. 10.1007\/s12072-015-9675-4","journal-title":"Hepatol Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault NA","year":"2018","unstructured":"Terrault NA, Lok AS, McMahon BJ, et al.. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018, 67:1560-99. 10.1002\/hep.29800","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305785","article-title":"Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma","volume":"63","author":"Liu J","year":"2014","unstructured":"Liu J, Yang HI, Lee MH, et al.. Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma. Gut. 2014, 63:1648-57. 10.1136\/gutjnl-2013-305785","journal-title":"Gut"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.11.031","article-title":"Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance","volume":"62","author":"Kim GA","year":"2015","unstructured":"Kim GA, Lee HC, Kim MJ, et al.. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance. J Hepatol. 2015, 62:1092-9. 10.1016\/j.jhep.2014.11.031","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13634","article-title":"Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance","volume":"43","author":"Liu F","year":"2016","unstructured":"Liu F, Wang XW, Chen L, Hu P, Ren H, Hu HD. Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance. Aliment Pharmacol Ther. 2016, 43:1253-61. 10.1111\/apt.13634","journal-title":"Aliment Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2011-300115","article-title":"The kidney speaks: interpreting urinary sodium and osmolality","volume":"96","author":"Bockenhauer D","year":"2011","unstructured":"Bockenhauer D, Aitkenhead H. The kidney speaks: interpreting urinary sodium and osmolality. Arch Dis Child Educ Pract Ed. 2011, 96:223-7. 10.1136\/archdischild-2011-300115","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00481","article-title":"The relation between thyroid function and anemia: a pooled analysis of individual participant data","volume":"103","author":"Wopereis DM","year":"2018","unstructured":"Wopereis DM, Du Puy RS, van Heemst D, et al.. The relation between thyroid function and anemia: a pooled analysis of individual participant data. J Clin Endocrinol Metab. 2018, 103:3658-67. 10.1210\/jc.2018-00481","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.9540","article-title":"Association of testosterone levels with anemia in older men: a controlled clinical trial","volume":"177","author":"Roy CN","year":"2017","unstructured":"Roy CN, Snyder PJ, Stephens-Shields AJ, et al.. Association of testosterone levels with anemia in older men: a controlled clinical trial. JAMA Intern Med. 2017, 177:480-90. 10.1001\/jamainternmed.2016.9540","journal-title":"JAMA Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline","volume":"101","author":"Fleseriu M","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH. Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016, 101:3888-921. 10.1210\/jc.2016-2118","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00225-9","article-title":"Thyroid function in critically ill patients","volume":"3","author":"Fliers E","year":"2015","unstructured":"Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 2015, 3:816-25. 10.1016\/S2213-8587(15)00225-9","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022673","article-title":"Hyperprolactinemia in clinical non-functional pituitary macroadenomas: a STROBE-compliant study","volume":"99","author":"Lyu L","year":"2020","unstructured":"Lyu L, Yin S, Hu Y, et al.. Hyperprolactinemia in clinical non-functional pituitary macroadenomas: a STROBE-compliant study. Medicine (Baltimore). 2020, 99:e22673. 10.1097\/MD.0000000000022673","journal-title":"Medicine (Baltimore)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/er.2015-1042","article-title":"Pituitary apoplexy","volume":"36","author":"Briet C","year":"2015","unstructured":"Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P. Pituitary apoplexy. Endocr Rev. 2015, 36:622-45. 10.1210\/er.2015-1042","journal-title":"Endocr Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1530\/EO-21-0033","article-title":"Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal?","volume":"2","author":"Pekic S","year":"2022","unstructured":"Pekic S, Stojanovic M, Popovic V. Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal?. Endocr Oncol. 2022, 2:R1-R13. 10.1530\/EO-21-0033","journal-title":"Endocr Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1210\/mend.11.4.9911","article-title":"Isolation and characterization of a pituitary tumor-transforming gene (PTTG)","volume":"11","author":"Pei L","year":"1997","unstructured":"Pei L, Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol. 1997, 11:433-41. 10.1210\/mend.11.4.9911","journal-title":"Mol Endocrinol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/1066896909356105","article-title":"Immunohistochemical expression of pituitary tumor transforming gene (PTTG) in pituitary adenomas: a correlative study of tumor subtypes","volume":"18","author":"Salehi F","year":"2010","unstructured":"Salehi F, Kovacs K, Scheithauer BW, Cantelmi D, Horvath E, Lloyd RV, Cusimano M. Immunohistochemical expression of pituitary tumor transforming gene (PTTG) in pituitary adenomas: a correlative study of tumor subtypes. Int J Surg Pathol. 2010, 18:5-13. 10.1177\/1066896909356105","journal-title":"Int J Surg Pathol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-3561","article-title":"PTTG1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression","volume":"83","author":"Zhou Q","year":"2023","unstructured":"Zhou Q, Li L, Sha F, et al.. PTTG1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression. Cancer Res. 2023, 83:2372-86. 10.1158\/0008-5472.CAN-22-3561","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23468","article-title":"Expression of pituitary tumor-transforming gene 1 (PTTG1)\/securin in hepatitis B virus (HBV)-associated liver diseases: evidence for an HBV X protein-mediated inhibition of PTTG1 ubiquitination and degradation","volume":"51","author":"Molina-Jim\u00e9nez F","year":"2010","unstructured":"Molina-Jim\u00e9nez F, Benedicto I, Murata M, et al.. Expression of pituitary tumor-transforming gene 1 (PTTG1)\/securin in hepatitis B virus (HBV)-associated liver diseases: evidence for an HBV X protein-mediated inhibition of PTTG1 ubiquitination and degradation. Hepatology. 2010, 51:777-87. 10.1002\/hep.23468","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2005.03919.x","article-title":"Clinical features of hepatocellular carcinoma with extrahepatic metastases","volume":"20","author":"Natsuizaka M","year":"2005","unstructured":"Natsuizaka M, Omura T, Akaike T, et al.. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol. 2005, 20:1781-7. 10.1111\/j.1440-1746.2005.03919.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216104","article-title":"Hepatoid adenocarcinoma-clinicopathological features and molecular characteristics","volume":"559","author":"Li M","year":"2023","unstructured":"Li M, Mei YX, Wen JH, Jiao YR, Pan QR, Kong XX, Li J. Hepatoid adenocarcinoma-clinicopathological features and molecular characteristics. Cancer Lett. 2023, 559:216104. 10.1016\/j.canlet.2023.216104","journal-title":"Cancer Lett"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2020.08.027","article-title":"The diagnostic approach in complex patients: parsimony or plenitude?","volume":"134","author":"Kelly J","year":"2021","unstructured":"Kelly J. The diagnostic approach in complex patients: parsimony or plenitude?. Am J Med. 2021, 134:11-2. 10.1016\/j.amjmed.2020.08.027","journal-title":"Am J Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1515\/dx-2022-0093","article-title":"Occam's razor and Hickam's dictum: a dermatologic perspective","volume":"10","author":"Stein H","year":"2023","unstructured":"Stein H, Lowenstein EJ. Occam's razor and Hickam's dictum: a dermatologic perspective. Diagnosis (Berl). 2023, 10:96-9. 10.1515\/dx-2022-0093","journal-title":"Diagnosis (Berl)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/256486-beyond-occams-razor-concurrent-non-functional-pituitary-macroadenoma-and-metastatic-hepatocellular-carcinoma-in-a-patient-with-functional-cure-of-hepatitis-b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T03:27:01Z","timestamp":1718335621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/256486-beyond-occams-razor-concurrent-non-functional-pituitary-macroadenoma-and-metastatic-hepatocellular-carcinoma-in-a-patient-with-functional-cure-of-hepatitis-b"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.62339","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,13]]}}}